327 related articles for article (PubMed ID: 21730835)
1. Factor XI and XII as antithrombotic targets.
Müller F; Gailani D; Renné T
Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D; Renné T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
[TBL] [Abstract][Full Text] [Related]
3. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
[TBL] [Abstract][Full Text] [Related]
4. Factor XI and factor XII as targets for new anticoagulants.
Weitz JI
Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
[TBL] [Abstract][Full Text] [Related]
5. Are hemostasis and thrombosis two sides of the same coin?
Colman RW
J Exp Med; 2006 Mar; 203(3):493-5. PubMed ID: 16533890
[TBL] [Abstract][Full Text] [Related]
6. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
van Montfoort ML; Meijers JC
Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
[TBL] [Abstract][Full Text] [Related]
8. Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis.
Rai V; Balters MW; Agrawal DK
Rev Cardiovasc Med; 2019 Dec; 20(4):245-253. PubMed ID: 31912715
[TBL] [Abstract][Full Text] [Related]
9. Factor XI and contact activation as targets for antithrombotic therapy.
Gailani D; Bane CE; Gruber A
J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012
[TBL] [Abstract][Full Text] [Related]
10. Role of Factor XII in hemostasis and thrombosis: clinical implications.
Renné T; Gailani D
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
[TBL] [Abstract][Full Text] [Related]
11. Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives.
Vlădăreanu AM; Roşca A
Rom J Intern Med; 2024 Jun; 62(2):91-100. PubMed ID: 38153875
[TBL] [Abstract][Full Text] [Related]
12. Activation of factor XI in plasma is dependent on factor XII.
Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
[TBL] [Abstract][Full Text] [Related]
13. Emerging anticoagulant strategies.
Fredenburgh JC; Gross PL; Weitz JI
Blood; 2017 Jan; 129(2):147-154. PubMed ID: 27780803
[TBL] [Abstract][Full Text] [Related]
14. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
15. The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
Nickel KF; Labberton L; Long AT; Langer F; Fuchs TA; Stavrou EX; Butler LM; Renné T
Thromb Res; 2016 May; 141 Suppl 2():S4-7. PubMed ID: 27207422
[TBL] [Abstract][Full Text] [Related]
16. The rebirth of the contact pathway: a new therapeutic target.
Srivastava P; Gailani D
Curr Opin Hematol; 2020 Sep; 27(5):311-319. PubMed ID: 32740037
[TBL] [Abstract][Full Text] [Related]
17. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.
Tucker EI; Marzec UM; White TC; Hurst S; Rugonyi S; McCarty OJ; Gailani D; Gruber A; Hanson SR
Blood; 2009 Jan; 113(4):936-44. PubMed ID: 18945968
[TBL] [Abstract][Full Text] [Related]
18. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
[TBL] [Abstract][Full Text] [Related]
19. An Update on Safe Anticoagulation.
Mailer RK; Kuta P; Renné T
Hamostaseologie; 2022 Feb; 42(1):65-72. PubMed ID: 35196732
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC; Meijers JC; Monia BP; Levi M
J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
